Saikishore Meruva
About Saikishore Meruva
Saikishore Meruva is a Scientist in Oral Drug Product Development at Bristol Myers Squibb, with extensive experience in pharmaceutical formulation and development.
Title and Role at Bristol Myers Squibb
Saikishore Meruva currently holds the position of Scientist in Oral Drug Product Development at Bristol Myers Squibb. Based in New Brunswick, New Jersey, he focuses on advancing the development of oral drug products. His responsibilities might include formulating drug dosage, ensuring product stability, and adhering to design and quality principles in pharmaceutical development.
Previous Experience at Biogen
Prior to his current role, Saikishore worked at Biogen as Sr. Engineer I in Formulation and Technical Development from 2020 to 2021. Located in Cambridge, Massachusetts, his work at Biogen involved the formulation and development of pharmaceutical products, likely engaging in tasks related to excipient compatibility and stability, as well as solubility and permeability assessments.
Educational Background
Saikishore Meruva earned his Doctor of Philosophy (PhD) in Pharmaceutical Sciences from the University of Iowa, concluding his studies in 2020 after five years. He also holds a Master’s Degree in Industrial Pharmacy from Campbell University, completed in 2014. Additionally, he achieved a Bachelor's Degree in Pharmacy from Osmania University in 2012. His academic journey provided him with a robust foundation in pharmaceutical sciences.
Research and Internship Experience
Throughout his career, Saikishore garnered significant research and practical experience through various internships and roles. He interned at Celgene multiple times between 2017 and 2019, focusing on drug product development and formulation. Additionally, he contributed as a Graduate Research Assistant at the University of Iowa for five years, gaining hands-on experience in developing pharmaceutical formulations and conducting solid-state characterization.
Technical Skills and Expertise
Saikishore Meruva possesses extensive technical skills in pharmaceutical formulation and drug product development. He has developed mini-tablets for pediatric use, applied Design of Experiments (DoE) and Quality by Design (QbD) principles, and conducted various assessments such as solubility, permeability, and stability studies. His expertise also includes the development and management of drug product manufacturing processes and analytical methods, as well as solid-state characterization techniques including TGA, DSC, PXRD, and particle size analysis.